High prevalence of undiagnosed patients with peripheral arterial disease in patients hospitalised for non-vascular disorders

International Journal of Clinical Practice

Volumn 62, Issue 1, 2008, Pages 59-64

  Lacroix, P ^a,b   Aboyans, V ^a,b   Voronin, D ^a   Le Guyader, A ^a   Cautres M ^a   Laskar, M ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

^b UNIVERSITY OF LIMOGES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFIDENCE INTERVAL; CONTROLLED STUDY; EDINBURGH CLAUDICATION QUESTIONNAIRE; FEMALE; HOSPITAL PATIENT; HUMAN; INTERMITTENT CLAUDICATION; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; POPULATION RESEARCH; PRESCRIPTION; PREVALENCE; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PULSE WAVE; QUESTIONNAIRE; RANDOMIZATION; REVASCULARIZATION; TERTIARY HEALTH CARE;

ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; FEMALE; FRANCE; HOSPITALIZATION; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PLATELET AGGREGATION INHIBITORS; PREVALENCE;

EID: 37349047765     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/j.1742-1241.2007.01579.x     Document Type: Article

References (24)

1. Norgren L, Hiatt WR, Dormandy JA et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 2007 45 : S5 67.
2. Mohler ER. Peripheral arterial disease. Identification and implication. Arch Intern Med 2003 163 : 2306 14.
3. Antithrombotic Trialit's Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002 324 : 71 86.
4. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo controlled trial. Lancet 2002 536 : 7 22.
5. Ostergren J, Sleight P, Dagenais G et al. HOPE study investigators. Impact of ramipril in patients with evidence of clinical or subclinical peripheral arterial disease. Eur Heart J 2004 25 : 17 24.
6. Poldermans D, Boersma E, Bax JJ et al. The effect of bisoprolol on peri-operative mortality and myocardial infarction in high-risk patient undergoing vascular surgery. N Engl J Med 1999 341 : 1789 94.
7. Poldermans D, Boersma E, Bax JJ et al. Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J 2001 22 : 1353 8.
8. Feringa HHH, van Waning VH, Bax JJ et al. Cardioprotective medication is associated with improved survival in patients with peripheral arterial disease. J Am Coll Cardiol 2006 47 : 1182 7.
9. Mc Grae Mc Dermott M, Greenland P, Liu K et al. Leg symptoms in peripheral arterial disease. Associated clinical characteristics and functional impairment. JAMA 2001 286 : 1599 606.
10. Hirsch AT, Haskal ZJ, Hertzer NR. ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary. J Am Coll Cardiol 2006 47 : 1239 312.
11. Resnick HE, Lindsay RS, Mc Dermott MM et al. Relationship of high and low ankle brachial index to all-cause mortality. The Strong Heart Study. Circulation 2004 109 : 733 9.
12. Aboyans V, Lacroix P, Postil A et al. Subclinical peripheral arterial disease and incompressible ankle arteries are both long-term pronostic factors in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2005 46 : 815 20.
13. Lacroix P, Aboyans V, Boissier C et al. Validation of a French translation of the Edinburgh claudication questionnaire among general practitioners' patients. Arch Mal Coeur Vaiss 2002 95 : 596 600.
14. Leng GC, Fowkes FG. The Edinburgh Claudication Questionnaire: an improved version of the WHO/Rose Questionnaire for use in epidemiological surveys. J Clin Epidemiol 1992 45 : 1101 9.
15. Aboyans V, Lacroix P, Lebourdon A et al. The intra- and interobserver variability of ankle-arm blood pressure index according to its mode of calculation. J Clin Epidemiol 2003 56 : 215 20.
16. Diehm C, Lange S, Darius H et al. Association of low ankle brachial index with high mortality in primary care. Eur Heart J 2006 27 : 1743 9.
17. Hirsch AT, Criqui MH, Treat-Jacobson D et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001 286 : 1317 24.
18. Boccalon H, Lehert P, Mosnier M. Assessment of the prevalence of atherosclerotic lower limb arteriopathy in France as a systolic index in a vascular risk population. J Mal Vasc 2000 25 : 38 46.
19. Antonopoulos S, Kokoris S, Stasini F et al. High prevalence of subclinical peripheral artery disease in Greek hospitalised patients. Eur J Int Med 2005 16 : 187 91.
20. Fowkes FGR, Low LP, Tuta S, Kozak J. Ankle-brachial index and extent of atherothrombosis in 8891 patients with or at risk of vascular disease: results of the international AGATHA study. Eur Heart J 2006 27 : 1861 7.
21. Blacher J, Cacoub P, Luizy F et al. Peripheral arterial disease versus other localizations of vascular disease: the ATTEST study. J Vasc Surg 2006 44 : 314 8.
22. Clagett GP, Sobel M, Jackson MR et al. Antithrombotic therapy in peripheral arterial occlusive disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 126 : 609S 26S.
23. Aronow W, Ahn C. Effect of beta blockers on incidence of new coronary event in older persons with prior myocardial infarction and symptomatic peripheral arterial disease. Am J Cardiol 2001 87 : 1284 6.
24. McGrae Mc Dermott M, Liu K, Criqui M et al. Ankle-brachial index and subclinical cardiac and carotid disease. The Multi-Ethnic Study of atherosclerosis. Am J Epidemiol 2005 162 : 33 41.